SonarMD

Overview
News
Preventive Healthcare?
Product stageSegments
Go-to-Market
?
Chronic Care Management
?

SonarMD is a care coordination company that focuses on gut health, specifically for patients with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. The company's platform combines multi-payer claims data, clinical information, and patient-reported outcome measures to identify patients who may benefit from additional support services. SonarMD uses AI technology and algorithms to predict clinical deterioration in patients, enabling early intervention before issues escalate to hospitalizations or emergency department visits.

The company's approach involves enrolling patients and periodically assessing their health status through validated surveys like the Crohn's Disease Activity Index and Ulcerative Colitis Disease Activity Index. Based on the responses, SonarMD generates a personalized "Sonar Score" that represents the patient's condition. If the score or trend indicates a potential decline, SonarMD's care coordination team reaches out to the patient for more details and alerts the patient's healthcare provider, facilitating timely intervention.

SonarMD's technology-enabled care coordination program has proven effective in keeping patients healthier and reducing costs for health plans. In January 2024, research presented at the Crohn's & Colitis Congress showed that patients engaged with SonarMD had ten times fewer hospital admissions and emergency department visits compared to unengaged patients. SonarMD's approach has demonstrated a 50% reduction in ER visits and hospitalizations, saving 15% per IBD member per year, totaling USD 10 million in savings across its book of business as of November 2022.

Key customers and partnerships

SonarMD partners with major health plans, working with four plans that have a combined membership of over 67 million Americans as of November 2022. The company collaborates with healthcare providers, offering its platform to gastroenterology practices to help them proactively identify and address emerging health issues in patients with chronic gut conditions.

In October 2023, SonarMD formed a partnership with Telebelly Health, a virtual care platform for gastroenterology practices. This collaboration aims to help practices expand patient access and optimize the care experience by combining SonarMD's remote patient monitoring and care coordination capabilities with Telebelly Health's virtual consultations and digital intake services.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Chicago IL USA
Founded year:
2015
Employees:
11-50
IPO status:
Private
Total funding:
USD 15.3 mn
Last Funding:
USD 1.0 mn (Series Unknown; Jul 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.